{"canonical":"https://abierto.us/opportunities/75n91023r00024","key":"75N91023R00024","url":"https://abierto.us/opportunities/75n91023r00024","title":"A--PREVENT IDIQ MATO RFP","solicitation_number":"75N91023R00024","notice_type":"o","open":false,"response_deadline":"2023-02-28T15:00:00Z","first_posted":"2024-01-23","last_posted":"2024-09-16","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"NATIONAL INSTITUTES OF HEALTH","office":"NIH NCI","naics":"541714","psc":"AN12","set_aside":null,"place_state":null,"place_county":null,"place_county_name":null,"place_city":null,"place_city_name":null,"winner":"IIT RESEARCH INSTITUTE","award_amount":"149995000","publications":[{"notice_id":"565b59bb59ae4ce0ba0d74bd4fefd012","title":"PREVENT Cancer Preclinical Drug Development Program: Toxicology and Pharmacology Testing","solicitation_number":"75N91024D00001","notice_type":"a","base_type":"o","posted":"2024-01-23","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-07","award_number":"75N91024D00001","awardee_name":"IIT RESEARCH INSTITUTE Chicago","amount":"149995000.00","link_sam":"https://sam.gov/workspace/contract/opp/565b59bb59ae4ce0ba0d74bd4fefd012/view","enriched":false,"history":[]},{"notice_id":"045272fa52024c0fa6f50c0158581e19","title":"A--PREVENT Preclinical Efficacy & Endpoint Biomarkers","solicitation_number":"75N91023R00024","notice_type":"a","base_type":"a","posted":"2024-02-01","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-10","award_number":"75N91024D00003","awardee_name":"THE INSTITUTE FOR CANCER RESEARCH 333 COTTMAN AVENUE PHILADELPHIA PA 191112434 US","amount":"149995000","link_sam":"https://sam.gov/workspace/contract/opp/045272fa52024c0fa6f50c0158581e19/view","enriched":false,"history":[]},{"notice_id":"21852de14e454b62b14e13761138c1b4","title":"A--PREVENT Preclinical Efficacy & Endpoint Biomarkers","solicitation_number":"75N91023R00024","notice_type":"a","base_type":"a","posted":"2024-02-01","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-10","award_number":"75N91024D00004","awardee_name":"THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM 1515 HOLCOMBE BOULEVARD BOX 1676 HOUSTON TX 770304009 US","amount":"149995000","link_sam":"https://sam.gov/workspace/contract/opp/21852de14e454b62b14e13761138c1b4/view","enriched":false,"history":[]},{"notice_id":"a6c2438194dc45b485e2a64eced25537","title":"A--PREVENT Preclinical Efficacy & Biomarkers","solicitation_number":"75N91023R00024","notice_type":"a","base_type":"a","posted":"2024-02-01","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-10","award_number":"75N91024D00006","awardee_name":"WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 100654805 US","amount":"149995000","link_sam":"https://sam.gov/workspace/contract/opp/a6c2438194dc45b485e2a64eced25537/view","enriched":false,"history":[]},{"notice_id":"f642a53e12b7455f90ee6e1a063d04f3","title":"A--PREVENT Preclinical Efficacy & Endpoint Biomarkers","solicitation_number":"75N91023R00024","notice_type":"a","base_type":"a","posted":"2024-02-01","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-10","award_number":"75N91024D00005","awardee_name":"UNIVERSITY OF OKLAHOMA PO BOX 26901 URP865, SUITE 490 OKLAHOMA CITY OK 731260901 US","amount":"149995000","link_sam":"https://sam.gov/workspace/contract/opp/f642a53e12b7455f90ee6e1a063d04f3/view","enriched":false,"history":[]},{"notice_id":"3fca19a50da6422c9e851d530af91d68","title":"A--PREVENT IDIQ MATO RFP","solicitation_number":"75N91023R00024","notice_type":"o","base_type":"o","posted":"2024-09-16","posted_at":null,"due_at":"2023-02-28T15:00:00Z","due_date":"2023-02-28","cancelled":null,"archived":null,"archive_date":"2023-03-15","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/3fca19a50da6422c9e851d530af91d68/view","enriched":false,"history":[]}],"latest_notice_id":"3fca19a50da6422c9e851d530af91d68","first_type":"a","notices":[{"award":{"date":"2024-01-23","amount":"149995000.00","number":"75N91024D00001","awardee":{"raw":"IIT RESEARCH INSTITUTE Chicago IL 60616 USA","name":"IIT RESEARCH INSTITUTE Chicago","location":{"zip":"60616","state":{"code":"IL"},"country":{"code":"USA"}}}},"dates":{"posted":"2024-01-23","award_date":"2024-01-23"},"links":{"sam":"https://sam.gov/workspace/contract/opp/565b59bb59ae4ce0ba0d74bd4fefd012/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"PREVENT Cancer Preclinical Drug Development Program: Toxicology and Pharmacology Testing","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-07","archive_type":"auto15"},"contacts":[{"name":"Rachel Turk","role":"primary","email":"rachel.turk@nih.gov"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"565b59bb59ae4ce0ba0d74bd4fefd012","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"e4161c8fc7b1acec5d2b3f9af39c550e1c29e04a1702683e1733d5dcc0d44225","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91024D00001","product_service_code":"AN12"},{"award":{"date":"2024-01-24","amount":"149995000","number":"75N91024D00003","awardee":{"raw":"THE INSTITUTE FOR CANCER RESEARCH 333 COTTMAN AVENUE PHILADELPHIA PA 191112434 US","name":"THE INSTITUTE FOR CANCER RESEARCH 333 COTTMAN AVENUE PHILADELPHIA PA 191112434 US"}},"dates":{"posted":"2024-02-01","award_date":"2024-01-24"},"links":{"sam":"https://sam.gov/workspace/contract/opp/045272fa52024c0fa6f50c0158581e19/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT Preclinical Efficacy & Endpoint Biomarkers","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-10","archive_type":"auto_custom"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"a","label":"Award Notice"},"notice_id":"045272fa52024c0fa6f50c0158581e19","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"5815dbe78b0502d35e6a08c9cbaa90fda13e63793b9eb60e9712d8786f2b2090","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ contract in support of the PREVENT Cancer Preclinical Drug Development Program","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91023R00024","product_service_code":"AN12"},{"award":{"date":"2024-01-24","amount":"149995000","number":"75N91024D00004","awardee":{"raw":"THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM 1515 HOLCOMBE BOULEVARD BOX 1676 HOUSTON TX 770304009 US","name":"THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM 1515 HOLCOMBE BOULEVARD BOX 1676 HOUSTON TX 770304009 US"}},"dates":{"posted":"2024-02-01","award_date":"2024-01-24"},"links":{"sam":"https://sam.gov/workspace/contract/opp/21852de14e454b62b14e13761138c1b4/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT Preclinical Efficacy & Endpoint Biomarkers","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-10","archive_type":"auto_custom"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"a","label":"Award Notice"},"notice_id":"21852de14e454b62b14e13761138c1b4","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"c05d4cec5f9960ba1494d1eecb57807fc5ee92ed6d700dcc6fb78726d206d5ad","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ contract in support of the PREVENT Cancer Preclinical Drug Development Program","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91023R00024","product_service_code":"AN12"},{"award":{"date":"2024-01-24","amount":"149995000","number":"75N91024D00006","awardee":{"raw":"WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 100654805 US","name":"WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 100654805 US"}},"dates":{"posted":"2024-02-01","award_date":"2024-01-24"},"links":{"sam":"https://sam.gov/workspace/contract/opp/a6c2438194dc45b485e2a64eced25537/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT Preclinical Efficacy & Biomarkers","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-10","archive_type":"auto_custom"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"a","label":"Award Notice"},"notice_id":"a6c2438194dc45b485e2a64eced25537","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"3c7f5e696d36e9ab8f5e29314b3fbd020d645154548a25758a51c9a0b0776a0a","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ contract in support of the PREVENT Cancer Preclinical Drug Development Program","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91023R00024","product_service_code":"AN12"},{"award":{"date":"2024-01-24","amount":"149995000","number":"75N91024D00005","awardee":{"raw":"UNIVERSITY OF OKLAHOMA PO BOX 26901 URP865, SUITE 490 OKLAHOMA CITY OK 731260901 US","name":"UNIVERSITY OF OKLAHOMA PO BOX 26901 URP865, SUITE 490 OKLAHOMA CITY OK 731260901 US"}},"dates":{"posted":"2024-02-01","award_date":"2024-01-24"},"links":{"sam":"https://sam.gov/workspace/contract/opp/f642a53e12b7455f90ee6e1a063d04f3/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT Preclinical Efficacy & Endpoint Biomarkers","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-10","archive_type":"auto_custom"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"a","label":"Award Notice"},"notice_id":"f642a53e12b7455f90ee6e1a063d04f3","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"39ec2c747087bd3eb90ca7ee0d1ce63211afabf29235ba61e4d052c1739768d5","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ contract in support of the PREVENT Cancer Preclinical Drug Development Program","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91023R00024","product_service_code":"AN12"},{"dates":{"posted":"2024-09-16","response_deadline":{"raw":"2023-02-28T10:00:00-05:00","utc":"2023-02-28T15:00:00Z","date":"2023-02-28","time":"10:00:00","utc_offset_seconds":-18000}},"links":{"sam":"https://sam.gov/workspace/contract/opp/3fca19a50da6422c9e851d530af91d68/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT IDIQ MATO RFP","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2023-03-15","archive_type":"auto15"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"3fca19a50da6422c9e851d530af91d68","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"5cfa89221c7cccf9fa6fe2460430e0bba800a3635a0f9c2e78a09735d63cbe99","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing. See attached for additional details.","origin":"extract"},"notice_type":{"code":"o","label":"Solicitation"},"schema_version":1,"solicitation_number":"75N91023R00024","product_service_code":"AN12"}],"due_at":"2023-02-28T15:00:00Z","due_date":"2023-02-28","closes_at":"2023-02-28T15:00:00Z","awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N910","office_name":"NIH NCI","state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner_key":"DGBUFQYMKWB5","amount":"149995000","linked_awards":36,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"3fca19a50da6422c9e851d530af91d68","description":{"text":"Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing. See attached for additional details.","html":null,"origin":"extract"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"place_of_performance":null,"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"naics_codes":["541714"],"award":null,"attachments":[],"awards":[{"award_key":"CONT_IDV_75N91024D00001_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00001_7529/","piid":"75N91024D00001","parent_piid":null,"award_type":null,"vendor_key":"DGBUFQYMKWB5","recipient_name":"IIT RESEARCH INSTITUTE","recipient_uei":"DGBUFQYMKWB5","recipient_cage":"03889","recipient_city":"CHICAGO","recipient_state":"IL","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-23","last_action_date":"2026-07-15","actions":7,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY TESTING","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00002_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00002_7529/","piid":"75N91024D00002","parent_piid":null,"award_type":null,"vendor_key":"W8XEAJDKMXH3","recipient_name":"UNIVERSITY OF ILLINOIS","recipient_uei":"W8XEAJDKMXH3","recipient_cage":"1YGW1","recipient_city":"CHICAGO","recipient_state":"IL","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-23","last_action_date":"2025-01-31","actions":4,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY TESTING","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00003_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00003_7529/","piid":"75N91024D00003","parent_piid":null,"award_type":null,"vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-24","last_action_date":"2026-06-29","actions":5,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00004_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00004_7529/","piid":"75N91024D00004","parent_piid":null,"award_type":null,"vendor_key":"S3GMKS8ELA16","recipient_name":"THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER","recipient_uei":"S3GMKS8ELA16","recipient_cage":"0KD38","recipient_city":"HOUSTON","recipient_state":"TX","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-24","last_action_date":"2026-06-30","actions":5,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00005_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00005_7529/","piid":"75N91024D00005","parent_piid":null,"award_type":null,"vendor_key":"GY8NMUZQXVS7","recipient_name":"UNIVERSITY OF OKLAHOMA","recipient_uei":"GY8NMUZQXVS7","recipient_cage":"4B862","recipient_city":"OKLAHOMA CITY","recipient_state":"OK","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-24","last_action_date":"2026-07-09","actions":6,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00006_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00006_7529/","piid":"75N91024D00006","parent_piid":null,"award_type":null,"vendor_key":"YNT8TCJH8FQ8","recipient_name":"WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY","recipient_uei":"YNT8TCJH8FQ8","recipient_cage":"1UMU6","recipient_city":"NEW YORK","recipient_state":"NY","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-24","last_action_date":"2026-08-31","actions":5,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00008_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00008_7529/","piid":"75N91024D00008","parent_piid":null,"award_type":null,"vendor_key":"PW5LPREDN9N5","recipient_name":"CURIA BIO INC","recipient_uei":"PW5LPREDN9N5","recipient_cage":"9TMX2","recipient_city":"BELMONT","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-09-13","last_action_date":"2026-06-25","actions":2,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":2,"description":"PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: CGMP","method":"solicitation","confidence":"high","evidence":["solicitation number 75N91023R00024 equals the FPDS solicitation identifier","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null}],"related":[{"key":"75N98026R00109","latest_notice_id":"5ab4cf48d42c495aabef1d6cdf21acf8","title":"NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM","solicitation_number":"75N98026R00109","notice_type":"o","first_type":"o","first_posted":"2026-07-10","last_posted":"2026-08-10","notices":5,"due_at":"2026-09-21T21:00:00Z","due_date":"2026-09-21","closes_at":"2026-09-21T21:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N910","office_name":"NIH NCI","naics":"54171","psc":"AN12","set_aside":"SBA","state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"}]}